Institut Catalá d´Oncología (I.C.O.)

L'Hospitalet de Llobregat, Barcelona 08907

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Renal Cell, Pancreatic Ductal Carcinoma

Studies at this site

• A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC) — Completed
• A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma — Stopped early